@ZephyrEnergyPlc "While the early results on this single well are fantastic and demonstrate commerciality, I am even more encouraged when considering the potential implications for the broader development of our Paradox project."
@ZephyrEnergyPlc I could not be more pleased with the initial results from this latest production test. Our team has worked exceptionally hard to crack the code to deliver highly economic production from this under-explored basin, & with today's news I believe we have made huge strides forward
@CanyonResources Peter Secker is a disaster who has driven everything he has done into the ground. Investors look at his past history independently and BE WARNED. This is not good for Canyon imo.
@MattFry667142@MacleanDave@General_Rastus Well, it was my post Matt. I suppose back when it was below 0.04p you were saying it would never reach 0.4p
Just my opinion that we've got at least another 10 bags to go from here. #MOS is a tiny fish with an huge chunk of BET in our pocket.
@Towlie1981 Fantastic interview. What an amazing potential these new pro-drugs have. Will literally be life changing / saving for thousands if not millions
@Darrenukdaytra1 Cheapest and only way to buy in to BET if you want exposure to LatAm betting market.
What do we have to hit and sustain to fill the gap Darren?
We are seriously motoring & only just approaching last year's placing price. 4-5 bags still to go her. Looking for 1p with BET live.
@glr_1990 P1 is NOT efficacy. It's safety. Why can't you bother to read up before commenting???
There are people on the AVA6000 P1 study that wouldn't be expected to respond to Doxorubicin under any circumstances.
P1 is to see if AVA6000 kills them or not? It doesn't. It's a winner.
@connell_m1@GolfNut48846224@DeutscheBank He's a sham. Knows nothing about the detail of Avacta's therapeutics development and has demonstrated that in spades. Add the conflict re his wife to that, why he is allowed to continue issuing notes on #AVCT by DB is unbelievable. Clearly an agenda to damage the SP
@timkempster Another moronic troll suckered by someone who forgot to mention is that his wife was sacked by Avacta and ever since he's been on a vendetta against the company. How he can be allowed to write about #AVCT as an analyst is a joke!
@ActiveValue1 That is about as moronic comment as it's possible to make Kevin Taylor. Why don't you read about clinical trial phases before you spout off trying to troll Avacta. P1 is for safety and not efficacy. For you who may not understand: If it doesn't kill people that is good result